AND PURPOSE: Dizziness associated with central neurological disorders-broadly defined as dizziness or vertigo attributable to central nervous system pathology affecting central vestibular processing-is a clinically challenging and heterogeneous condition with limited treatment options....
This meta-analysis may support Ginkgo biloba as an adjunct for dizziness in central neurological conditions, but audiologists managing vestibular patients should review the included study quality carefully before recommending it, as evidence in purely peripheral vestibular disorders may not be applicable.
Dizziness is a common complaint managed by audiologists and vestibular specialists; a systematic synthesis of Ginkgo biloba evidence could influence supplement counseling and integrative care recommendations.
- 01Systematic review and meta-analysis of Ginkgo biloba extract for dizziness in central neurological disorders.
- 02Pooled analysis provides higher-level evidence than individual studies alone.
- 03Findings apply to central (brain-based) dizziness, not necessarily inner-ear (peripheral) vestibular disorders.
- 04Ginkgo biloba is widely used but regulatory status and dosing vary internationally.
- 05Clinicians should assess included trial quality; many Ginkgo studies have methodological limitations.
Ginkgo biloba extract reduces dizziness-related symptoms in patients with central neurological disorders.
studypartially supported- PMID
- 42394931
- DOI
- 10.3389/fneur.2026.1860538.
- Journal
- Frontiers in Neurology
- Publication type
- meta_analysis
- Evidence level
- 1a
- Population
- Patients with dizziness or vertigo associated with central neurological disorders
- Intervention
- Ginkgo biloba extract
- Comparator
- Placebo or active comparator (varies by included study)
Primary outcomes
Dizziness symptom severity; Vertigo frequency or intensity